Thilo Schroeder retweeted
Listen to Episode 42 of @BioVentureVoiCe video podcast w/ @schroederthilo, Managing Partner at @NextechInvest. Thilo shares how the firm has evolved since he joined in 2012 and how the focus on oncology therapeutics has paid off with many successful M&As and IPOs, despite cancer drugs being one of the highest risk therapeutic categories. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): biotechtv.com/post/bioventur…
𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, @schroederthilo describes his investment philosophy and focus on precision oncology.
Full video: biotechtv.com/post/bioventur…
Thilo Schroeder retweeted
Besides being an all around great guy, @schroederthilo's track record has been unbelievable: Revolution, Blueprint, Parabilis, Peloton....and the firm was also an early investor in Tubulis. This is a great discussion with @cngarabedian that I highly recommend bookmarking.
𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, @schroederthilo describes his investment philosophy and focus on precision oncology.
Full video: biotechtv.com/post/bioventur…
Thank you @bradloncar for the conversation. It was great having you in Zurich at @NextechInvest HQ. We love being stealthy at Nextech but appreciate your broad casting.
𝐅𝐫𝐨𝐦 𝐙𝐮𝐫𝐢𝐜𝐡: Biotech investor @schroederthilo of @NextechInvest shares his take on biotech and discusses portfolio companies Revolution Medicines, Tubulis, and Circle Pharma.
Full video: biotechtv.com/post/thilo-sch…
Thilo Schroeder retweeted
Our story with the groups of Don Scott and Markus Kaiser on Molecular Glues of the 14-3-3/ChREBP complex is out in Nature Communications:
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity | Nature Communications
Thilo Schroeder retweeted
Super good at a first glance $tyra , let’s see what tomorrow brings.
ir.tyra.bio/news-releases/ne…
Thilo Schroeder retweeted
$RVMD How often do you see mPFS (8.1 months) better than benchmark mOS (6.x months) in solid tumors ?
Thilo Schroeder retweeted
Novartis has entered into an agreement to acquire Mariana Oncology, building on radioligand therapy pipeline and commitment to RLT innovation. go.novartis.social/3UJXqkt
Thilo Schroeder retweeted
Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these cancer treatments with a new acquisition.
statnews.com/2024/05/02/nova… $NVS
Thilo Schroeder retweeted
Today, we announced a $100 million private placement. This financing, together with Context's existing cash and cash equivalents, is expected to extend our cash runway into 2028. $CNTX ir.contexttherapeutics.com/n…
What can it not do 🤔
The list of utility for GLP-1 drugs with just expanded to obesity plus sleep apnea (tirzepatide vs placebo results of 2 new randomized trials via company, first drug treatment ever to show efficacy vs sleep apnea)
usatoday.com/story/news/heal… @USATODAYhealth by
@eduardomcuevas @kweintraub
Beautiful
I stand at the seashore, alone, and start to think.
There are the rushing waves
mountains of molecules
each stupidly minding its own business
trillions apart
yet forming white surf in unison.
Ages on ages
before any eyes could see
year after year
thunderously pounding the shore as now.
For whom, for what?
On a dead planet
with no life to entertain.
Never at rest
tortured by energy
wasted prodigiously by the sun
poured into space.
A mite makes the sea roar.
Deep in the sea
all molecules repeat
the patterns of one another
till complex new ones are formed.
They make others like themselves
and a new dance starts.
Growing in size and complexity
living things
masses of atoms
DNA, protein
dancing a pattern ever more intricate.
Out of the cradle
onto dry land
here it is
standing:
atoms with consciousness;
matter with curiosity.
Stands at the sea,
wonders at wondering: I
a universe of atoms
an atom in the universe.
Just incredible!
$RVMD
Out in @Nature concurrent with #AACR24
Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer
@KenOliveLab @BenStanger01 @derlabunc
nature.com/articles/s41586-0…
nature.com/articles/s41586-0…
Thilo Schroeder retweeted
This explained my whole childhood within a minute
xitter.cf/tannokasa4/status/1731…
Not a good business to be in IPOs when all the good companies get acquired prior to listing.
$GMAB Genmab to Acquire ProfoundBio for $1.8 Billion in Cash.
ProfoundBio is developing next-generation ADCs and ADC technologies for the treatment of certain cancers.
businesswire.com/news/home/2…
@AlteromeTx is a very strong company in the @NextechInvest portfolio and we are excited by the strong investors that join us to bring two remarkable molecules (targets to be announced) to clinical POC. Congrats Eric&Scott on closing the strong financing!
